Noxopharm Limited Stock Price on February 16, 2024
If you're considering investing in Noxopharm Pink Sheet, it is important to understand the factors that can impact its price. Noxopharm Limited has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. By analyzing Noxopharm's technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk.
Noxopharm Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Noxopharm |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
NOXOF |
Based on monthly moving average Noxopharm is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Noxopharm by adding Noxopharm to a well-diversified portfolio.
Noxopharm Valuation on February 16, 2024
It is possible to determine the worth of Noxopharm on a given historical date. On February 16, 2024 Noxopharm was worth 0.03 at the beginning of the trading date compared to the closed value of 0.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Noxopharm pink sheet. Still, in general, we apply an absolute valuation method to find Noxopharm's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Noxopharm where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Noxopharm's related companies.
Open | High | Low | Close | Volume | |
0.03 | 0.03 | 0.03 | 0.03 | 1.00 | |
02/16/2024 | 0.03 | 0.03 | 0.03 | 0.03 | 1.00 |
0.03 | 0.03 | 0.03 | 0.03 | 1.00 |
Backtest Noxopharm | | | Noxopharm History | | | Noxopharm Valuation | Previous | Next |
Noxopharm Trading Date Momentum on February 16, 2024
On February 20 2024 Noxopharm Limited was traded for 0.03 at the closing time. The highest daily price throughout the period was 0.03 and the lowest price was 0.03 . There was no trading activity during the period 1.0. Lack of trading volume on 02/20/2024 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
Noxopharm Limited Fundamentals Correlations and Trends
By evaluating Noxopharm's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Noxopharm's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Noxopharm financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Noxopharm Pink Sheet history
Noxopharm investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Noxopharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Noxopharm Limited will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Noxopharm stock prices may prove useful in developing a viable investing in Noxopharm
Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. The company was incorporated in 2015 and is based in Chatswood, Australia. Noxopharm operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Noxopharm Pink Sheet Technical Analysis
Noxopharm technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Noxopharm Period Price Range
Low | February 16, 2024
| High |
0.03 | 0.03 |
Noxopharm May 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Noxopharm pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Noxopharm shares will generate the highest return on investment. By undertsting and applying Noxopharm pink sheet market strength indicators, traders can identify Noxopharm Limited entry and exit signals to maximize returns
Rate Of Daily Change | 1.0 | |||
Day Median Price | 0.03 | |||
Day Typical Price | 0.03 | |||
Period Momentum Indicator | 0.015 | |||
Relative Strength Index | 100.0 |
Noxopharm Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Noxopharm's price direction in advance. Along with the technical and fundamental analysis of Noxopharm Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Noxopharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0815 | |||
Jensen Alpha | 0.4912 | |||
Total Risk Alpha | 0.0383 | |||
Treynor Ratio | 0.1823 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Noxopharm Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Noxopharm Pink Sheet analysis
When running Noxopharm's price analysis, check to measure Noxopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Noxopharm is operating at the current time. Most of Noxopharm's value examination focuses on studying past and present price action to predict the probability of Noxopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Noxopharm's price. Additionally, you may evaluate how the addition of Noxopharm to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Valuation Check real value of public entities based on technical and fundamental data |